• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2-氮杂以及2-氮杂氧化物-蒽二酮衍生物的拓扑异构酶II DNA切割刺激作用、DNA结合活性、细胞毒性及物理化学性质

Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives.

作者信息

De Isabella P, Palumbo M, Sissi C, Capranico G, Carenini N, Menta E, Oliva A, Spinelli S, Krapcho A P, Giuliani F C

机构信息

Division of Experimental Oncology B, Istituto Nazionale Tumori, Milan, Italy.

出版信息

Mol Pharmacol. 1995 Jul;48(1):30-8.

PMID:7623772
Abstract

The cytotoxic activity of mitoxantrone and related anthracenediones has been ascribed to the ability of these compounds to interfere with DNA topoisomerase II function, resulting in DNA cleavage stimulation. The molecular details of enzyme inhibition by these intercalating agents remain to be defined. In an attempt to identify the structural determinants for optimal activity, the molecular and cellular effects of a series of heteroanalogues bearing different side-chains were examined in relation to the physico-chemical and DNA binding properties of these compounds. The results indicated that substitution of a pyridine ring for the dihydroxyphenylene ring in the planar chromophore caused a marked reduction of cytotoxic activity and of the ability to stimulate topoisomerase II-mediated DNA damage in intact cells and with simian virus 40 DNA in vitro. Although all tested derivatives were shown to intercalate into DNA, their DNA binding affinities were appreciably lower than that of mitoxantrone. The behavior of 2-aza derivatives more closely resembled that of ametantrone, suggesting that the potency of agents of this class is influenced more by the presence of hydroxyl groups than by the phenylene ring. The observation that a dramatic reduction (or loss) of the ability of aza derivatives to stimulate DNA cleavage is associated with a marked reduction of cytotoxic potency supports a primary role of topoisomerase II-mediated effects in the mechanism of action of the effective agents of this class. Because appreciable cytotoxic activity and significant in vivo antitumor efficacy are retained by compounds inactive (or poorly active) in inhibition of topoisomerase II, these results are consistent with multiple effects of anthracenediones at the cellular level.

摘要

米托蒽醌及相关蒽二酮的细胞毒性活性归因于这些化合物干扰DNA拓扑异构酶II功能的能力,从而导致DNA裂解刺激。这些嵌入剂对酶的抑制作用的分子细节仍有待确定。为了确定最佳活性的结构决定因素,研究了一系列带有不同侧链的杂类似物的分子和细胞效应,并将其与这些化合物的物理化学性质和DNA结合特性相关联。结果表明,在平面发色团中用吡啶环取代二羟基苯环会导致细胞毒性活性以及在完整细胞中刺激拓扑异构酶II介导的DNA损伤的能力和在体外对猿猴病毒40 DNA的刺激能力显著降低。尽管所有测试衍生物均显示可嵌入DNA,但其与DNA的结合亲和力明显低于米托蒽醌。2-氮杂衍生物的行为更类似于氨茴环素,这表明此类药物的效力受羟基存在的影响大于苯环。氮杂衍生物刺激DNA裂解的能力显著降低(或丧失)与细胞毒性效力显著降低相关,这一观察结果支持了拓扑异构酶II介导的效应在这类有效药物作用机制中的主要作用。由于在抑制拓扑异构酶II方面无活性(或活性较差)的化合物仍保留了相当的细胞毒性活性和显著的体内抗肿瘤功效,这些结果与蒽二酮在细胞水平上的多种作用一致。

相似文献

1
Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives.2-氮杂以及2-氮杂氧化物-蒽二酮衍生物的拓扑异构酶II DNA切割刺激作用、DNA结合活性、细胞毒性及物理化学性质
Mol Pharmacol. 1995 Jul;48(1):30-8.
2
Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effects.米托蒽醌衍生物刺激下拓扑异构酶II DNA切割的序列选择性:与药物DNA结合及细胞效应的关系
Mol Pharmacol. 1993 May;43(5):715-21.
3
Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity.肽基蒽醌类作为潜在的抗肿瘤药物:合成、DNA结合、氧化还原循环及生物活性。
J Med Chem. 1996 Aug 2;39(16):3114-22. doi: 10.1021/jm950924a.
4
Binding of bis-substituted 2-aza-anthracenedione regioisomers to DNA: effects of the relative positioning of the side chains.双取代2-氮杂蒽二酮区域异构体与DNA的结合:侧链相对位置的影响
Anticancer Drug Des. 1999 Jun;14(3):265-74.
5
Novel antitumor indenoindole derivatives targeting DNA and topoisomerase II.靶向DNA和拓扑异构酶II的新型抗肿瘤茚并吲哚衍生物
Biochem Pharmacol. 2004 Nov 15;68(10):1911-22. doi: 10.1016/j.bcp.2004.07.008.
6
[In vitro stimulation by ellipticine derivatives of DNA cleavage induced by DNA topoisomerase II: a structure-activity relationship].[DNA拓扑异构酶II诱导的DNA切割的椭圆玫瑰树碱衍生物的体外刺激:构效关系]
Bull Cancer. 1994 Mar;81(3):194-202.
7
Intoplicine (RP 60475) and its derivatives, a new class of antitumor agents inhibiting both topoisomerase I and II activities.安托利辛(RP 60475)及其衍生物,一类新型抗肿瘤药物,可同时抑制拓扑异构酶I和II的活性。
Cancer Res. 1993 Dec 15;53(24):5987-93.
8
Inhibition of DNA topoisomerase II by imidazoacridinones, new antineoplastic agents with strong activity against solid tumors.咪唑并吖啶酮对DNA拓扑异构酶II的抑制作用,一类对实体瘤具有强大活性的新型抗肿瘤药物。
Mol Pharmacol. 1996 May;49(5):772-80.
9
Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance.阿霉素3'和4'位结构修饰对其捕获拓扑异构酶II及克服多药耐药能力的影响
Mol Pharmacol. 1994 May;45(5):908-15.
10
Topoisomerase II poisoning and antineoplastic action by DNA-nonbinding diacetyl and dicarboxaldoxime derivatives of ferrocene.二乙酰基和二羧醛肟二茂铁衍生物对拓扑异构酶II的中毒作用及抗肿瘤作用:DNA非结合机制
Arch Biochem Biophys. 2000 Apr 1;376(1):229-35. doi: 10.1006/abbi.1999.1692.

引用本文的文献

1
Interactions of pixantrone with apurinic/apyrimidinic sites in DNA.匹杉琼与DNA中脱嘌呤/脱嘧啶位点的相互作用。
MicroPubl Biol. 2024 Jun 8;2024. doi: 10.17912/micropub.biology.001207. eCollection 2024.
2
An evaluation of the interaction of pixantrone with formaldehyde-releasing drugs in cancer cells.柔红霉素与癌症细胞中释放甲醛的药物相互作用的评估。
Cancer Chemother Pharmacol. 2022 Jun;89(6):773-784. doi: 10.1007/s00280-022-04435-1. Epub 2022 Apr 23.
3
Mechanisms of drug resistance in acute myeloid leukemia.急性髓系白血病的耐药机制
Onco Targets Ther. 2019 Mar 11;12:1937-1945. doi: 10.2147/OTT.S191621. eCollection 2019.
4
Emerging small-molecule treatments for multiple sclerosis: focus on B cells.多发性硬化症的新兴小分子治疗方法:聚焦于B细胞。
F1000Res. 2019 Mar 1;8. doi: 10.12688/f1000research.16495.1. eCollection 2019.
5
Mechanisms of Action and Reduced Cardiotoxicity of Pixantrone; a Topoisomerase II Targeting Agent with Cellular Selectivity for the Topoisomerase IIα Isoform.匹杉琼的作用机制及降低的心脏毒性;一种对拓扑异构酶IIα同工型具有细胞选择性的拓扑异构酶II靶向剂
J Pharmacol Exp Ther. 2016 Feb;356(2):397-409. doi: 10.1124/jpet.115.228650. Epub 2015 Dec 11.
6
Pixantrone induces cell death through mitotic perturbations and subsequent aberrant cell divisions.匹杉琼通过有丝分裂扰动和随后的异常细胞分裂诱导细胞死亡。
Cancer Biol Ther. 2015;16(9):1397-406. doi: 10.1080/15384047.2015.1070979.
7
Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas.匹杉琼用于治疗复发或难治性侵袭性非霍奇金B细胞淋巴瘤的成年患者。
Onco Targets Ther. 2014 May 29;7:865-72. doi: 10.2147/OTT.S34055. eCollection 2014.
8
Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines - in vitro studies.没卡地酸增强脂质体米托蒽醌对黑素瘤细胞系的抗癌活性 - 体外研究。
Int J Nanomedicine. 2014 Jan 23;9:653-68. doi: 10.2147/IJN.S54911. eCollection 2014.
9
On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs.关于 II 型拓扑异构酶靶向抗癌药物的结构基础和设计准则。
Nucleic Acids Res. 2013 Dec;41(22):10630-40. doi: 10.1093/nar/gkt828. Epub 2013 Sep 14.
10
A physiologically based pharmacokinetic model of mitoxantrone in mice and scale-up to humans: a semi-mechanistic model incorporating DNA and protein binding.在小鼠和人体中米托蒽醌的基于生理的药代动力学模型:一种半机理模型,纳入 DNA 和蛋白质结合。
AAPS J. 2012 Jun;14(2):352-64. doi: 10.1208/s12248-012-9344-7. Epub 2012 Mar 27.